Close Menu

Biodesix

The serum-based proteomics test is now available in all 50 states.

While the company continues clinical studies showing the utility of its proteomics-based VeriStrat test in predicting response to cancer therapies, it also is forging partnerships with pharma for use of the test.

Movers & Shakers: Jan 7, 2011

Premium

Leroy Hood, Samuel Broder, Mark Velleca, Paul Beresford, Dino DiCamillo

The funding will go toward ongoing commercialization efforts for VeriStrat, the company's protein biomarker-based companion diagnostic for non-small cell lung cancer.

The money will go toward ongoing commercialization of VeriStrat, a serum proteomic-based test to help guide treatment of patients with non-small cell lung cancer.

A number of prominent proteomics-based diagnostics developers were recipients of the grant and tax credit awards, which are being provided by the IRS through the Patient Protection and Affordable Care Act's Qualifying Therapeutic Discovery Project Program.

NCI has outlined changes to its IP policies for collaborative research agreements that would essentially provide industry collaborators with first-option commercial licensing rights for IP arising from studies that make use of pharma companies' proprietary drugs, or samples from patients treated with those drugs.

Included are a method for predicting peptide detection via mass spectrometry; a method for purifying proteins; and a method of biomarker analysis.

A company official said that VeriStrat sales are growing at a double-digit pace and that Biodesix is also looking to apply the test to diseases beyond lung cancer.

In addition to several PGx studies presented at the conference, the International Association for the Study of Lung Cancer and the European Thoracic Oncology Platform's European EGFR Workshop Group proposed recommendations on EGFR mutation testing in NSCLC when patients are treated with AstraZeneca's Iressa.

Pages

The Atlantic reports another SARS-CoV-2 testing problem may be lurking: backlogs.

Researchers have sequenced the genome of "the Methuselah of freshwater fish."

The US Biomedical Advanced Research and Development Authority is supporting efforts to develop vaccines against SARS-CoV-2.

In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.